- Home
- BPOP vs ARWR Comparison
BPOP vs ARWR Comparison
Compare BPOP & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BPOP | ARWR |
|---|---|---|
| Founded | 1893 | 2003 |
| Country | United States | United States |
| Employees | 9427 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.8B | 10.2B |
| IPO Year | N/A | 2009 |
Fundamental Metrics
Financial Performance| Metric | BPOP | ARWR |
|---|---|---|
| Price | $160.10 | $76.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 10 |
| Target Price | ★ $160.18 | $83.40 |
| AVG Volume (30 Days) | 413.9K | ★ 1.3M |
| Earning Date | 04-23-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.03% | N/A |
| EPS Growth | N/A | ★ 99.80 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $16,142,321.00 |
| Revenue This Year | $12.86 | N/A |
| Revenue Next Year | $5.79 | N/A |
| P/E Ratio | $11.87 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $102.56 | $14.30 |
| 52 Week High | $161.26 | $82.26 |
Technical Indicators
Market Signals| Indicator | BPOP | ARWR |
|---|---|---|
| Relative Strength Index (RSI) | 69.79 | 55.00 |
| Support Level | $123.14 | $70.19 |
| Resistance Level | N/A | $77.39 |
| Average True Range (ATR) | 2.86 | 3.71 |
| MACD | 0.95 | -0.20 |
| Stochastic Oscillator | 85.17 | 69.79 |
Price Performance
Historical ComparisonAbout BPOP Popular Inc.
Popular Inc, based in Puerto Rico, is a financial holding company with four main subsidiaries: Banco Popular de Puerto Rico, a bank in Puerto Rico in terms of assets; Banco Popular North America, its banking operation in the continental United States; Evertec, a data processor; and Popular Financial Holdings, a diversified financial services company. The Corporation's reportable segments consist of Banco Popular de Puerto Rico and Popular U.S.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.